Accelerate Diagnostics Achieves ISO 13485 Certification and Initial Installations of Accelerate ID/AST System
March 16, 2015 14:15 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 16, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic...
Accelerate Diagnostics to Present at the Cowen and Company 35th Annual Health Care Conference on March 4, 2015
February 25, 2015 05:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 07, 2015 05:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
November 03, 2014 13:50 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
September 25, 2014 14:35 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Sept. 25, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...